2025 annual financial data
ADMA Biologics 2025 Operating margin
ADMA Biologics 2025 operating margin with verified reported values.
Direct answer
Operating margin was 37.53%.
Operating income was 191,443,000 USD and net income was 146,930,000 USD.
Operating cash flow was 50,396,000 USD.
Get free ADMA Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 510,173,000 USD
- Operating income
- 191,443,000 USD
- Net income
- 146,930,000 USD
- Operating cash flow
- 50,396,000 USD